Private equity firm JLL Partners Inc. has announced two acquisitions in the healthcare sector, picking up BioClinica (Nasdaq: BIOC), a provider of clinical trial management, and CoreLab Partners Inc., a provider of medical imaging and cardiac safety services.

While terms of the CoreLab deal remain undisclosed, New York-based JLL agreed to pay $7.25 a share for BioClinica, which results in an equity value of roughly $123 million.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.